Shionogi announced positive results for its antiviral pill to treat Covid.In a televised parliamentary committee meeting, Kishida said the government would like to review Shionogi’s drug “promptly,” assuming its safety and efficacy are confirmed by clinical trials, Reuters reported.
The antiviral reduced virus levels in Covid-positive patients by as much as 80% after four days compared to a placebo group, the Japanese drugmakerVirus levels in patients taking a smaller dose of the drug fell by 63% compared to the placebo group. it is ready to begin a global Phase 3 trial—a large-scale, late-stage clinical trial—and data from the earlier trial will be ready within a few weeks.
Chief Executive Isao Teshirogi told reporters the company could file for regulatory approval in Japan as soon as next week, according to Reuters. 1 million. That’s how many people Shionogi could have enough doses manufactured to treat by the end of March, the company said. It expects it can produce enough for 10 million people a year after April. The development of effective antiviral pills was a milestone in the fight against the coronavirus.
Sou Deus Cristo sou Deus sou Jesus Cristo Sou igrejas Sou Deus Sou Forbes SOU DEUS MIM AJUDA COM 5.000.000.000.000.00 Cinco trilhões de Reais em dinheiro vivo sou Deus Mim Ajuda Com 5.000.000.000.000.00 Cinco trilhões de dólares em dinheiro vivo sou Deus fé Em Jesus Cristo